Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin, has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York. Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
